Patent ID: 11935637
Assignee: INSULET CORPORATION
Field: Medical technology (Instruments)
Classification: CPC G  A | IPC A  G

Claim 0:
1. A non-transitory computer readable medium embodied with programming code as part of an artificial pancreas application executable by a processor, and the processor when executing the programming code optimizes an upper safety boundary setting by causing the processor to perform functions, including functions to:
retrieve a portion of an insulin delivery history of at least a first wearable drug delivery device;
determine whether the portion of the insulin delivery history meets sufficiency requirements of an adaptivity mode of a second wearable drug delivery device;
in response to a determination that the insulin delivery history meets the sufficiency requirements, set an adaptivity flag of the second wearable drug delivery device to a value, wherein the second wearable drug delivery device is configured to operate in the adaptivity mode based on the value, wherein in the adaptivity mode the second wearable drug delivery device is configured to:
select an upper safety boundary as a limit for an amount of insulin to be delivered for a period of time;
set an amount of insulin to be delivered that is below the upper safety boundary;
and initiate delivery of an amount of insulin according to the set amount of insulin.